Navigating Germline Implications of Clinical Tumor Testing

This Pediatric Hematology-Oncology Research Seminar Series session will take place on January 14, 2021 at 8:00 A.M. Attendance for this seminar will only be available through Zoom.

CME Information

Needs Statement

Clinical and research faculty, graduate and medical students, clinical and postdoctoral fellows, and research nurses in pediatric hematology-oncology need to be regularly updated on the latest data from clinical trials in pediatric patients with hematological-oncological disorders, on the advances in the development of targeted therapies, on the developments in ethical/legal issues related to end of life care, and on the new practice standards for follow-up care for long-term survivors. The series aims to increase knowledge and skills of the learners in these topic areas in order to enhance the quality of care, increase patient safety, and improve patient outcomes.

Objectives

At the conclusion of the sessions, the participants should be able to:

  • Discuss new research data in pediatric hematologic and oncologic disorders and incorporate these data into clinical and research activities.
  • Identify ethical and legal issues pertaining to clinical care and research activities pertaining to pediatric hematology and oncology.
  • Evaluate drug development in pediatric cancers and blood disorders.
  • Analyze and interpret the significance of long-term survivorship issues in pediatric cancer and hematologic disorders.
  • Develop an understanding of how QI cycles can be applied to a specific and common clinical problem.
  • Learn how to improve communication between clinical teams in different medical settings.

Target Audience

  • Physicians
  • Medical Students
  • Fellows
  • Residents
  • Nurses

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Director

  1. Terzah Horton, M.D., Ph.D.

    Terzah Horton, M.D., Ph.D.

    Assistant Professor
    Baylor College of Medicine

Disclosure Policy

The Office of Continuing Medical Education (OCME) makes every effort to develop CME activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial SupportSM, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: 1) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.

Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.

If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME activity evaluation candidly.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenter

  1. Sarah Scollon, M.S., C.G.C.

    Sarah Scollon, M.S., C.G.C.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Program Director

  1. Terzah Horton, M.D., Ph.D.

    Terzah Horton, M.D., Ph.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:
    • Research Support: Takeda Pharmaceuticals

Planning Committee Members

  1. Matthew Campbell, M.D. Placeholder Image

    Matthew Campbell, M.D.

    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Terzah Horton, M.D., Ph.D.

    Terzah Horton, M.D., Ph.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:
    • Research Support: Takeda Pharmaceuticals
  3. YoungNa Lee-Kim, M.D. Placeholder Image

    YoungNa Lee-Kim, M.D.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  4. Donald Williams Parsons, M.D., Ph.D.

    Donald Williams Parsons, M.D., Ph.D.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

CME Credit Available

You may claim CME credit after watching this activity.

View the CME Information

Presenter:

  1. Sarah Scollon, M.S., C.G.C.

    Sarah Scollon, M.S., C.G.C.

    Assistant Professor Baylor College of Medicine